Synaptogenix Inc (SNPX)
4.57
-0.14
(-2.97%)
USD |
NASDAQ |
May 10, 16:00
4.605
+0.04
(+0.77%)
After-Hours: 20:00
Synaptogenix Market Cap: 4.960M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 4.960M |
| May 09, 2024 | 5.112M |
| May 08, 2024 | 5.047M |
| May 07, 2024 | 5.079M |
| May 06, 2024 | 5.112M |
| May 03, 2024 | 5.524M |
| May 02, 2024 | 5.166M |
| May 01, 2024 | 5.242M |
| April 30, 2024 | 5.144M |
| April 29, 2024 | 4.832M |
| April 26, 2024 | 4.916M |
| April 25, 2024 | 4.789M |
| April 24, 2024 | 4.949M |
| April 23, 2024 | 4.960M |
| April 22, 2024 | 4.732M |
| April 19, 2024 | 4.699M |
| April 18, 2024 | 5.058M |
| April 17, 2024 | 5.209M |
| April 16, 2024 | 5.047M |
| April 15, 2024 | 4.797M |
| April 12, 2024 | 5.086M |
| April 11, 2024 | 5.237M |
| April 10, 2024 | 5.101M |
| April 09, 2024 | 5.361M |
| April 08, 2024 | 5.850M |
| Date | Value |
|---|---|
| April 05, 2024 | 5.426M |
| April 04, 2024 | 4.911M |
| April 03, 2024 | 4.884M |
| April 02, 2024 | 4.990M |
| April 01, 2024 | 4.984M |
| March 28, 2024 | 5.087M |
| March 27, 2024 | 5.169M |
| March 26, 2024 | 5.372M |
| March 25, 2024 | 4.961M |
| March 22, 2024 | 5.076M |
| March 21, 2024 | 5.264M |
| March 20, 2024 | 5.334M |
| March 19, 2024 | 5.725M |
| March 18, 2024 | 5.345M |
| March 15, 2024 | 5.481M |
| March 14, 2024 | 4.884M |
| March 13, 2024 | 4.857M |
| March 12, 2024 | 4.748M |
| March 11, 2024 | 4.830M |
| March 08, 2024 | 4.433M |
| March 07, 2024 | 4.420M |
| March 06, 2024 | 4.474M |
| March 05, 2024 | 4.632M |
| March 04, 2024 | 4.534M |
| March 01, 2024 | 4.926M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.809M
Minimum
Sep 20 2023
84.21M
Maximum
Oct 12 2021
28.21M
Average
29.88M
Median
Mar 24 2021
Market Cap Benchmarks
| CEL-SCI Corp | 76.65M |
| AIM ImmunoTech Inc | 19.96M |
| IGC Pharma Inc | 32.82M |
| NovaBay Pharmaceuticals Inc | 2.420M |
| Protalix BioTherapeutics Inc | 80.36M |
Market Cap Related Metrics
| Price to Book Value | 0.2037 |
| Price | 4.57 |
| Earnings Yield | -947.0% |